Biogen Inc. entered into an agreement to issue $1.75 billion in senior notes, including $400 million due in 2031, $650 million due in 2035, and $700 million due in 2055, on May 6, 2025, to help retire existing debt and for general corporate purposes. The sale was completed on May 12, 2025.